Why Is Intellia Therapeutics Stock Trading Lower On Friday?
Intellia Therapeutics(NTLA) Benzinga·2025-01-10 18:30On Thursday, Intellia Therapeutics Inc NTLA outlined its strategic priorities for 2025, emphasizing the acceleration of late-stage programs for NTLA-2002 and nex-z.These therapies target hereditary angioedema (HAE) and transthyretin (ATTR) amyloidosis, respectively.Intellia prioritized NTLA-2002 and nex-z while discontinuing the NTLA-3001 program and other early-stage initiatives.The reorganization will result in a 27% workforce reduction and a projected $8 million restructuring charge in early 2025.Intelli ...